World Financial News Network Recommends Health Discovery Showing Bright Future for Earnings Growth

Dr. Joseph de Beauchamp of World Financial News Network started coverage and gives favorable analysis to Health Discovery showing bright future for earnings growth by finding ways to help people with cancer, heart disease, obesity and AIDS.

Seattle, WA (PRWEB) February 13, 2005 -- WFNN's consistently outperforms established industry benchmark indicators. Based on in-depth research and analysis, their analysts recommend securities worldwide showing the highest probability for stock price appreciation. With constant vigil, WFNN looks for economic opportunities in the private and public company sectors.

Dr. Joseph de Beauchamp, WFNN's Chief Independent Analyst, said, Health Discovery shows as a leader to the identification of biomarkers and pathways in leukemia and lung development. They hope will be instrumental in diagnosing and treating patients with devastating diseases like cancer, heart disease, obesity and AIDS. Wfnn sees the breakthroughs in the company helping them move to the next level. This area of medical need continues to drive this company into the limelight. In the next twelve months, WFNN expects to see the stock move up to the two dollar range ($2.00) with more attention coming to this sector."

For brief information of this new, dynamic company, examine: http://wfnn.info displaying in the search engine section.

About WFNN: World Financial News Network provides a unique blend of data, timely information and today's technologies to assist with up-to-the-minute investment and economic values on markets and investments around the world.

About Health Discovery: Health products will be based on intellectual property, which includes the discovered biomarkers and pathways produced through their own internal research programs, as well as joint discovery efforts with academic institutions, diagnostic and pharmaceutical companies worldwide. Their discovery process has already been shown to lead to the identification of biomarkers and pathways in leukemia and lung development and they hope will be instrumental in diagnosing and treating patients with devastating diseases like cancer, heart disease, obesity and AIDS.

Health Discovery Corporation

6709 Waters Avenue

Savannah, GA 31406

866-953-9031

Stephen Barnhill, M.D. - Chairman and CEO

drbarnhill@healthdiscoverycorp.com

http://www.healthdiscoverycorp.com

###